Found "AI": 1,091 results
Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option
Abstract
Background
Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines.
Objective
To determine the cost-utility of 10- and 13-valent pneumococcal conjugate vacci
Economic costs of alcohol use in Sri Lanka
Abstract
Aim
Alcohol related disease conditions are responsible for a significant proportion of morbidity and mortality in Sri Lanka. This study quantified the economic cost of selected alcohol related disease conditions in Sri Lanka in 2015.
Methods
This study uses the prevalence-based cost
An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities.
Abstract
BACKGROUND:
Structural chromosome abnormalities can cause significant negative reproductive outcomes as they typically result in morbidity and mortality of newborns. The prevalence of structural chromosomal abnormalities in live births is at least 0.05%, of which many of them have paren
The EQ-5D-5L Valuation study in Thailand
Abstract
BACKGROUND:
At present, health technology assessment (HTA) guidelines of many countries including Thailand have recommended EQ-5D as the preferred method for assessing utility. This study aims to generate an EQ-5D-5L value set based on societal preferences of Thai population.
METHODS
A real-world study of effectiveness of intravitreal bevacizumab and ranibizumab injection for treating retinal diseases in Thailand
Abstract
Background
To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating patients with retinal diseases in Thailand.
Methods
A prospective, multi-centre, observational study was conducted among eight hospitals in t
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study
Abstract
Background
There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) treatments in Thailand and low- and middle-income countries. Moreover, findings from the ex
Leaving No One Behind: Participatory Technology Appraisal as a Platform for Agenda Setting to Address Disparities in Access to Health Services in Thailand.
Abstract
OBJECTIVES:
This article discusses how participatory technology appraisal as part of the Universal Coverage Scheme (UCS) in Thailand contributes to improving access to essential health services among vulnerable populations.
METHODS:
Document review was conducted on health technology
Anxiety at First and Subsequent Pregnancies and Its Associated Factors: A Historical Cohort Study From Northeastern Thailand
Abstract
Objective: To estimate and compare the prevalences of anxiety at first and subsequent pregnancies and explore its associated factors. Material and Methods: The study was conducted among multiparous women aged <34 years admitted to the post-partum ward in a regional hospital in northea
Economic Evaluation of Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Indonesia
Abstract
Background
This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost.
Methods
Based on a societal perspective, a model-based economic evaluation
Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link
Abstract
Background
Health surveillance and survey data are helpful in evidence-informed policy decisions. This study is part of an evaluation of the National Health Examination Survey (NHES) programme in Thailand. This paper focuses on the obstacles in the translation of survey information into
10 / Page